Same-day discharge in selected patients undergoing atrial fibrillation ablation.


Journal

Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944

Informations de publication

Date de publication:
11 2019
Historique:
received: 19 05 2019
revised: 02 09 2019
accepted: 16 09 2019
pubmed: 21 9 2019
medline: 22 9 2020
entrez: 21 9 2019
Statut: ppublish

Résumé

Atrial fibrillation (AF) ablation is a complex procedure, generally requiring at least one overnight hospital stay. We investigated the safety and feasibility of early mobilization and same-day discharge following streamlined peri-ablation management for AF. From 2014, we offered same-day discharge to selected patients who underwent uncomplicated AF ablation on the morning lists, with ultrasound-guided femoral access, uninterrupted warfarin or minimal interruption in novel oral anticoagulants, and reversal of intraprocedural heparin with protamine. Patients were discharged 6-8 h postprocedure and offered access to a dedicated nurse helpline. Of 1599 AF ablation cases performed from April 2014 to March 2017, 811 (50.7%) were performed on the morning lists and 169/811 (20.8%) were discharged on the same day. Excluding 26 research cases, 1/143 (0.7%) had transient right phrenic nerve palsy and five (3.5%) cases experienced minor problems that did not preclude same-day discharge; three (2.1%) needed rehospitalization postdischarge: one for pericarditic chest pain and two for nausea/vomiting. Compared to 642 overnight cases, day-case procedures were shorter, more likely to be redos, to be performed under sedation rather than general anesthesia, and less likely to involve linear lesions and electrical cardioversion. There were no significant differences in patient age, gender, body mass index, CHA Selective same-day discharge after AF ablation is safe and feasible using a streamlined peri-procedural care protocol. Wider adoption can potentially reduce health-care costs while improving patient experience.

Sections du résumé

BACKGROUND
Atrial fibrillation (AF) ablation is a complex procedure, generally requiring at least one overnight hospital stay. We investigated the safety and feasibility of early mobilization and same-day discharge following streamlined peri-ablation management for AF.
METHODS
From 2014, we offered same-day discharge to selected patients who underwent uncomplicated AF ablation on the morning lists, with ultrasound-guided femoral access, uninterrupted warfarin or minimal interruption in novel oral anticoagulants, and reversal of intraprocedural heparin with protamine. Patients were discharged 6-8 h postprocedure and offered access to a dedicated nurse helpline.
RESULTS
Of 1599 AF ablation cases performed from April 2014 to March 2017, 811 (50.7%) were performed on the morning lists and 169/811 (20.8%) were discharged on the same day. Excluding 26 research cases, 1/143 (0.7%) had transient right phrenic nerve palsy and five (3.5%) cases experienced minor problems that did not preclude same-day discharge; three (2.1%) needed rehospitalization postdischarge: one for pericarditic chest pain and two for nausea/vomiting. Compared to 642 overnight cases, day-case procedures were shorter, more likely to be redos, to be performed under sedation rather than general anesthesia, and less likely to involve linear lesions and electrical cardioversion. There were no significant differences in patient age, gender, body mass index, CHA
CONCLUSIONS
Selective same-day discharge after AF ablation is safe and feasible using a streamlined peri-procedural care protocol. Wider adoption can potentially reduce health-care costs while improving patient experience.

Identifiants

pubmed: 31538362
doi: 10.1111/pace.13807
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1448-1455

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Chugh S, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study. Circulation. 2014;129:837-847.
Go AS. The epidemiology of atrial fibrillation in elderly persons: The tip of the iceberg. Am J Geriatr Cardiol. 2005;14:56-61.
Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J. 2006;27:949-953.
Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2016;13:501.
Kotecha D, Breithardt G, Camm AJ, et al. Integrating new approaches to atrial fibrillation management: The 6th AFNET/EHRA consensus conference. Europace. 2018.
Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK. Heart. 2004;90:286-292.
Johnsen SP, Dalby LW, Tackstrom T, Olsen J, Fraschke A. Cost of illness of atrial fibrillation: A nationwide study of societal impact. BMC Health Serv Res. 2017;17:714.
Zoni Berisso M, Landolina M, Ermini G, et al. The cost of atrial fibrillation in Italy: A five-year analysis of healthcare expenditure in the general population. From the Italian Survey of Atrial Fibrillation Management (ISAF) study. Eur Rev Med Pharmacol Sci. 2017;21:175-183.
Ha AC, Wijeysundera HC, Birnie DH, Verma A. Real-world outcomes, complications, and cost of catheter-based ablation for atrial fibrillation: An update. Curr Opin Cardiol. 2017;32:47-52.
Andrade JG, Macle L, Nattel S, Verma A, Cairns J. Contemporary atrial fibrillation management: A comparison of the current AHA/ACC/HRS, CCS, and ESC guidelines. Can J Cardiol. 2017;33:965-976.
Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20:e1-e160.
January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1-76.
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609-1678.
Senoo K, Lau YC, Lip GY. Updated NICE guideline: Management of atrial fibrillation (2014). Expert Rev Cardiovasc Ther. 2014;12:1037-1040.
Casarett D, Karlawish JH, Sugarman J. Determining when quality improvement initiatives should be considered research: Proposed criteria and potential implications. JAMA. 2000;283:2275-2280.
Das M, Loveday JJ, Wynn GJ, et al. Ablation index, a novel marker of ablation lesion quality: Prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace. 2017;19:775-783.
Das M, Wynn GJ, Saeed Y, et al. Pulmonary vein re-isolation as a routine strategy regardless of symptoms: The PRESSURE randomized controlled trial. JACC Clin Electrophysiol. 2017;3:602-611.
Ghannam M, Chugh A, Dillon P, et al. Protamine to expedite vascular homeostasis after catheter ablation of atrial fibrillation: A randomized controlled trial. Heart Rhythm. 2018. https://doi.org/10.1016/j.hrthm.2018.06.045. in press.
Wynn GJ, Haq I, Hung J, et al. Improving safety in catheter ablation for atrial fibrillation: A prospective study of the use of ultrasound to guide vascular access. J Cardiovasc Electrophysiol. 2014;25:680-685.
Hussein A, Das M, Chaturvedi V, et al. Prospective use of ablation index targets improves clinical outcomes following ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2017;28:1037-1047.
Stroker E, de Asmundis C, Saitoh Y, et al. Anatomic predictors of phrenic nerve injury in the setting of pulmonary vein isolation using the 28-mm second-generation cryoballoon. Heart Rhythm. 2016;13:342-351.
Saitoh Y, Stroker E, Irfan G, et al. Fluoroscopic position of the second-generation cryoballoon during ablation in the right superior pulmonary vein as a predictor of phrenic nerve injury. Europace. 2016;18:1179-1186.
Mondesert B, Andrade JG, Khairy P, et al. Clinical experience with a novel electromyographic approach to preventing phrenic nerve injury during cryoballoon ablation in atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:605-611.
Franceschi F, Dubuc M, Guerra PG, et al. Diaphragmatic electromyography during cryoballoon ablation: A novel concept in the prevention of phrenic nerve palsy. Heart Rhythm. 2011;8:885-891.
Kalbfleisch SJ, el-Atassi R, Calkins H, Langberg JJ, Morady F. Safety, feasibility and cost of outpatient radiofrequency catheter ablation of accessory atrioventricular connections. J Am Coll Cardiol. 1993;21:567-570.
Marijon E, Albenque JP, Boveda S, et al. Feasibility and safety of same-day home discharge after radiofrequency catheter ablation. Am J Cardiol. 2009;104:254-258.
Wolber T, On CJ, Brunckhorst C, et al. Patient satisfaction and clinical outcome following outpatient radiofrequency catheter ablation of supraventricular tachycardia. Swiss Med Wkly. 2010;140:52-56.
Haegeli LM, Duru F, Lockwood EE, et al. Feasibility and safety of outpatient radiofrequency catheter ablation procedures for atrial fibrillation. Postgrad Med J. 2010;86:395-398.
Opel A, Mansell J, Butler A, et al. Comparison of a high throughput day case atrial fibrillation ablation service in a local hospital with standard regional tertiary cardiac centre care. Europace. 2018;21:440-444.
Ignacio DM, Jarma DJJ, Nicolas V, et al. Current safety of pulmonary vein isolation in paroxysmal atrial fibrillation: First experience of same day discharge. J Atr Fibrillation. 2018;11:2077.
Cardoso R, Mendirichaga R, Fernandes G, et al. Cryoballoon versus radiofrequency catheter ablation in atrial fibrillation: A meta-analysis. J Cardiovasc Electrophysiol. 2016;27:1151-1159.
Buiatti A, von Olshausen G, Barthel P, et al. Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: An updated meta-analysis of randomized and observational studies. Europace. 2017;19:378-384.
Di Biase L, Conti S, Mohanty P, et al. General anesthesia reduces the prevalence of pulmonary vein reconnection during repeat ablation when compared with conscious sedation: Results from a randomized study. Heart Rhythm. 2011;8:368-372.
Arbelo E, Brugada J, Hindricks G, et al. The atrial fibrillation ablation pilot study: A European survey on methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. Eur Heart J. 2014;35:1466-1478.
Guhl EN, Siddoway D, Adelstein E, et al. Incidence and predictors of complications during cryoballoon pulmonary vein isolation for atrial fibrillation. J Am Heart Assoc. 2016;5:e003724.
Muthalaly RG, John RM, Schaeffer B, et al. Temporal trends in safety and complication rates of catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2018;29:854-860.
Kalla M, Rajappan K, Kalra S, et al. Routine transthoracic echocardiography to assess pericardial collections in patients after extensive left atrial catheter ablation: A prospective study. J Cardiovasc Electrophysiol. 2011;22:756-760.
Cappato R, Calkins H, Chen SA, et al. Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: A worldwide report. J Am Coll Cardiol. 2011;58:2696-2697.

Auteurs

Stefano Bartoletti (S)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.

Mandeep Mann (M)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.

Akanksha Gupta (A)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.

Abdul Muhaymin Khan (AM)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.

Ankita Sahni (A)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.

Moutaz El-Kadri (M)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.
Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.

Simon Modi (S)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.

Johan Waktare (J)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.

Saagar Mahida (S)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.

Mark Hall (M)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.

Richard Snowdon (R)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.

Derick Todd (D)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.

Dhiraj Gupta (D)

Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.
Faculty of Health Sciences, University of Liverpool, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH